Status:
WITHDRAWN
Warrior CARE: Naturalistic Observation and Harm Reduction
Lead Sponsor:
Wayne State University
Conditions:
Post Traumatic Stress Disorder
Cannabis Use
Eligibility:
All Genders
19-69 years
Phase:
NA
Brief Summary
This study is looking at therapeutic potential of reducing Tetrahydrocannabinol (THC) levels in regular cannabis smokers using contingency management (CM) intervention in a U.S. veteran population wit...
Detailed Description
In this trial, the investigators will recruit veterans with post-traumatic stress disorder (PTSD) who report using cannabis. Veterans will be assigned (via participant self-selection) into either a na...
Eligibility Criteria
Inclusion
- able to provide informed consent, IQ Score \>80,
- served in branch of the US armed forces, report using cannabis,
- report using cannabis (at least 4x/month)
- test positive for THC in urine drug screen,
- meet DSM-5 criteria for PTSD w/ Sx of at least 6 months duration
Exclusion
- urine drug screen positive for any other drugs
- any clinically significant medical problems,
- any current or past serious psychotic or bipolar disorder diagnosis as determined by SCID-5
- at immediate high risk for suicide based on the C-SSRS
- current SUD other than Nicotine Use Disorder, Alcohol (mild or moderate) and Cannabis Use Disorder
- seeking treatment for Cannabis Use Disorder
Key Trial Info
Start Date :
July 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05386862
Start Date
July 13 2022
End Date
January 25 2024
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tolan Park Medical Building
Detroit, Michigan, United States, 48201